Evommune Inc.
EVMN | NYSE
$5.94
-$0.79 (-11.74%)
Nov 2, 2026, 1:42 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 10M | n/a | 3M | n/a | n/a | 7M |
Cost of Revenue | n/a | 349K | n/a | n/a | 375K | 377K | n/a | 325K | 271K |
Gross Profit | n/a | -349K | n/a | 10M | -375K | 2.62M | n/a | -325K | 6.73M |
Operating Income | -34.9M | -23.95M | -29.72M | -13.33M | -22.99M | -15.03M | -18.99M | -28.29M | -3.75M |
Interest Income | 2.65M | 2.28M | 1.44M | 862K | 404K | 613K | 727K | 917K | 981K |
Pretax Income | -32.25M | -21.67M | -28.27M | -12.48M | -13.57M | -14.56M | -18.32M | -27.38M | -2.78M |
Net Income | -32.25M | -21.67M | -28.27M | -12.48M | -13.57M | -14.56M | -18.32M | -27.38M | -2.78M |
Selling & General & Admin | 8.48M | 6.29M | 9.31M | 3.69M | 3.36M | 3.29M | 3.43M | 2.79M | 2.54M |
Research & Development | 26.41M | 17.32M | 20.4M | 19.64M | 19.64M | 14.36M | 15.56M | 25.18M | 7.95M |
Other Expenses | n/a | n/a | n/a | n/a | -375K | n/a | n/a | n/a | n/a |
Operating Expenses | 34.9M | 23.61M | 29.72M | 23.33M | 22.62M | 17.66M | 18.99M | 27.96M | 10.48M |
Interest Expense | n/a | n/a | n/a | n/a | 3K | 4K | n/a | 9K | 11K |
Selling & Marketing Expenses | n/a | n/a | 2.14M | n/a | n/a | n/a | 1.04M | n/a | n/a |
Cost & Expenses | 34.9M | 23.95M | 29.72M | 23.33M | 22.99M | 18.03M | 18.99M | 28.29M | 10.75M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 36.14M | 33.67M | 31.52M | 31.52M | 30.08M | 30.08M | 30.08M | 30.08M | 30.08M |
Shares Outstanding (Diluted) | 36.14M | 33.67M | 31.52M | 31.52M | 30.08M | 30.08M | 30.08M | 30.08M | 30.08M |
EPS (Basic) | -0.89 | -0.64 | -0.90 | -0.40 | -0.45 | -0.48 | -0.63 | -0.91 | -0.09 |
EPS (Diluted) | -0.89 | -0.64 | -0.90 | -0.40 | -0.45 | -0.48 | -0.63 | -0.91 | -0.09 |
EBITDA | -34.34M | -21.33M | -27.95M | -12.16M | -13.19M | -14.18M | -17.98M | -27.05M | -2.5M |
EBIT | -34.9M | -21.67M | -28.27M | -12.48M | -13.56M | -14.55M | -18.32M | -27.37M | -2.77M |
Depreciation & Amortization | 552K | 349K | 326K | 311K | 375K | 377K | 345.5K | 325K | 271K |
Add to Watchlist
Select watchlists to add or remove EVMN